|
Tereshkin N.A., Makashova V.V., Ponezheva Zh.B., Omarova Kh.G., Muzyka A.D., Gorelov A.V.
Prognostic value of serum biomarkers in case of chronic hepatitis C
|
№7 / 2024
|
|
Kanatbekova Zh.K., Shakhanov A.V., Uryasyev O.M., Nikiforov A.A.
Clinical significance of determining nitric oxide synthesis regulators in chronic obstructive pulmonary disease in comorbidity with arterial hypertension
|
№6 / 2024
|
|
Tanashyan M.M., Antonova K.V., Spryshkov N.E., Panina A.A.
Metabolic markers of cerebrovascular pathology
|
№5 / 2024
|
|
Avalueva E.B., Bakulin I.G., Skalinskaya M.I., Oganezova I.A., Sitkin S.I.
Immunological serum and plasma markers for the diagnosis of inflammatory bowel disease
|
№7 / 2022
|
|
Kravchenko A.Ya., Chernik T.A., Tokmachev R.E.
Soluble suppression of tumorigenicity 2 (sST2) in chronic heart failure
|
№4 (приложение) / 2022
|
|
Astapovsky A.A., Drozdov V.N., Shikh E.V., Lazareva N.B.
Adrenomedullin: biological functions and prospects for use as a biomarker in clinical practice
|
№4 / 2022
|
Русский
